-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
- C4 Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $296K, a 35.4% decline year-over-year.
- C4 Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.32M, a 32% decline year-over-year.
- C4 Therapeutics, Inc. annual Depreciation for 2023 was $1.58M, a 5.85% decline from 2022.
- C4 Therapeutics, Inc. annual Depreciation for 2022 was $1.68M, a 12.3% increase from 2021.
- C4 Therapeutics, Inc. annual Depreciation for 2021 was $1.49M, a 7.73% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)